Abstract

The mechanism for the blood glucose lowering effect of different ginger extracts is yet to be clearly understood, that of raw ginger extracts has been sparsely explored while the mechanism for the cooked ginger extract, the form in which it is mostly consumed, has not been delved into. This study was therefore designed to determine the effect of raw and cooked ginger (Zingiber officinale Roscoe) extracts on glucose uptake by the muscle and adipose of normal, streptozocin-induced and high-fat diet-induced diabetic rats. Fresh ginger rhizomes were washed, peeled, milled and sieved without adding water to obtain the raw extract. A portion of this was boiled for 1 hour to give the cooked extract. Matured male albino rats (140) were divided into two major groups with 70 rats in each group. Group A was further divided into 7 sub-groups (n=10) 40 of which were rendered diabetic with intraperitoneal injection of streptozocin (60mg/kg body weight) to mimic Type 1 diabetes while in Group B Type 2 diabetes was induced with a 12 week consumption of High-Fat Diet (HFD). The remaining 30 rats in each group were left to remain non-diabetic/ normal. Ginger extracts were administered as a daily oral dose for 4 weeks after diabetes induction. The animals were the sacrificed and glucose uptake by the muscle and adipose tissue was determined using standard analytical procedure. Mean data were compared using Least Significant Difference at p≤ 0.05. It was clearly evidenced that both raw and cooked ginger extracts significantly enhanced and increased glucose uptake by the muscle and adipose tissues even in the absence of insulin, hence, mimicking insulin action. Ginger in both raw and cooked forms may therefore be beneficial in the prevention and management of diabetes mellitus. Human trial is hereby recommended.

1. Introduction

Different extracts of ginger have been reported to effect blood glucose lowering effect in both laboratory animals and human subject with the two major types of diabetes mellitus. Mozaffari- Khosravi et al., ¹ reported the blood glucose and glycated hemoglobin lowering effect of daily oral dose of 3g ginger powder in Type 2 diabetic patients while Mahluji et al., ² reported no change in Fasting Blood Glucose (FBG) and cholesterol in Type 2 diabetic patients after daily oral dose of 2g ginger powder for 2 months. The prominent hypoglycemic component of ginger, [6]-gingerol, was observed to reduce FBG in insulin resistant diabetic obese mice ³ and in streptozotocin (STZ)-induced diabetic albino rats ⁴.

Aqueous ginger extract was reported to be effective in lowering blood glucose in STZ-induced diabetic rats ⁵ and alloxan-induced diabetic rats ⁶. More still, ginger powder (7% of diet), aqueous, methanolic ginger extracts and ginger oil also reduced FBG from 295.14mg/dl in diabetic control to 133.81, 125.19, 122.17 and 122.14mg/dl respectively in STZ-induced diabetic rats ⁷. All these ascertained the hypoglycemic effect of ginger but there are limited scientific findings on the hypoglycemic effect of raw ginger extract while there exists no report on the effect of cooked ginger extract (the form in which the spice is commonly consumed) on blood glucose.

Also fresh ginger juice (4ml/kg body weight) and dry ginger methanolic extract given at an oral dose of 0.5g/kg body weight reduced fasting blood glucose and increased serum insulin levels in streptozotocin-induced (90mg/kg body weight) diabetic rats ⁸, though the diabetes induced could not have been Type 1 diabetes mellitus as reported and the dose used in diabetic induction is a lethal dose. Acute effect of aqueous ginger extract (8g/kg body weight) administered intraperitoneally was similar to that of chlorpropamide in lowering blood glucose in STZ-induced diabetic rats ⁹ However, how the diabetic state was induced was not clearly stated. More still, methanolic ginger extract (250mg/kg body eight) produced a significant reduction in fructose-induced elevated lipid levels, body weight, hyperglycemia and hyperinsulinemia in rats while ethyl acetate extract of this spice only reduced body weight and lipid levels with no effect or change in the blood glucose and insulin levels ¹⁰. This was because the hypoglycemic agent in ginger (gingerol) was observed to be very low in the ethyl acetate extract. However the period for which the fructose was given to induce the diabetic state was not stated. Islam and Choi, ¹¹ reported no change in final body weight, fasting blood glucose, glycated hemoglobin and serum lipid profile in high-fat diet (22% fat) in STZ-induced diabetic rats after 4 weeks administration of freeze-dried ginger powder given at 2% of the diet but there was significant increase in serum insulin, though this did not result into a significant lowering of blood glucose. The report of Islam and Choi ¹¹ was in conflict with that of Nammi et al., ¹² who observed a significant reduction in body weight, fasting blood glucose, serum insulin, total cholesterol in high-fat diet fed rats which were given 400mg.kg body weight ethanol ginger extract. The variation in these reports could be as a result of differences in period of extracts’ administration or differences in the form of ginger used.

The blood glucose lowering effect of ginger was also affirmed by the report of Al-Qattan et al., ¹³. According to them raw ginger extract markedly reduced fasting serum glucose in STZ-induced diabetic rats after 7 weeks administration. Also nephropathy parameters (such as; capsular space shrinkage, glomerular hypertrophy and diffusion and cytoplasmic fragmentation) noticed in the diabetic control group were less prominent in the treated group ¹³. More still, aqueous extract of mixture of curry, garlic and ginger given at a daily oral dose of 300mg and 600 mg/kg body weight for 4 weeks exerted a blood glucose and lipid lowering effect on non-diabetic and alloxan-induced diabetic rats ¹⁴. Al-Moramadhi ¹⁵ reported a hypoglycemic and hypocholesterolemic effect of aqueous ginger extract given at a daily oral dose of 100mg/kg body weight for 6 weeks in broilers but no change was observed in body weight and food consumption. Similarly, petroleum ether, alcoholic and aqueous extracts of Zingiber officinale reduced blood glucose, serum cholesterol and triglyceride levels in both normal and alloxan-induced diabetic rats at acute and chronic administration ¹⁶. The active hypoglycemic agent in ginger (6-gingerol) was also observed to lower fasting blood glucose, plasma triglyceride, total cholesterol, low density lipoprotein cholesterol and plasma insulin concentration in type 2 diabetic db/db mice when given at a dose of 100mg/kg body weight ¹⁷. It also improved glucose tolerance and suppressed the generation of reactive oxygen species and restored the activity of catalase, superoxide dismutase and glutathione peroxidase (GPx) ¹⁷.

Al-Amin et al., ¹⁸ also affirmed the hypoglycemic and hypolipidemic effect of aqueous ginger extractin STZ-induced diabetic rats when administered at a daily oral dose of 500mg/kg body weight for 7 weeks. The extract was also able to reverse diabetic complication by reducing the urinary protein in the diabetic rats. Ojewole ¹⁹ reported the hypoglycemic effect of ethanolic ginger extract given at oral doses of 50-800 mg/kg bodyweight. This effect was observed to be dose dependent.

Elshater et al., ²⁰; Akhani et al., ²¹ and Sharma and Shukla, ²² reported the hypoglycemic effect of raw ginger juice (unpeeled) but fresh ginger is commonly peeled when used for culinary purposes.

Since it is an established fact that ginger lowers blood glucose, it is therefore imperative that the mechanism through which spice exerts be well understood in order for its proper application in diabetes prevention and management, a concept which is yet to be clearly understood. The possible mechanisms through which could influence the control the blood are: inhibition of carbohydrate digesting enzymes, reducing the absorption of glucose into the blood stream, enhancing the secretion of insulin, increasing glucose uptake by body cells and tissues and inhibiting hepatic production of glucose.

The majority (75%) of glucose uptake in the post prandial state is accomplished in the skeletal muscle in the skeletal muscle by the translocation of glucose transporter 4 (GLUT4) towards the membrane ²³. GLUT4 translocation in muscle cells is known to depend on two divergent signaling pathways. The first involves the binding of insulin to insulin receptor and the subsequent activation of phosphatidylinositol-3-kinase (PI3K) and Akt ²⁴. On the other hand 5’ adenosine monophosphate-activated protein kinase (AMPK), regarded as cellular energy sensor, has been reported to promote GLUT4 translocation independently of insulin ²⁵. Ethyl acetate ginger extract was observed to enhance glucose uptake in cell lines in mice by expressing GLUT4 in cell surface ²⁶. While [6]-gingerol also exerted similar effect via this mechanism as well as via induction or enhancement of AMPK phosphorylation in L6 myotubes ³. More still, [6]-gingerol regulated hepatic gene expression of enzymes related glucose metabolism towards reducing gluconeogenesis and glycogenolysis ³ which is similar to insulin influence as earlier explained. The enhancement of glucose uptake by reconstituted freeze-dried ginger juice was affirmed by Noipha and Ratanachaiyavong ²⁷. The ginger extract at 400µg/ml markedly increased glucose uptake in L6 myotubes after 20 hours incubation. This enhancement of glucose transport by ginger was as a result of increased expression of both GLUT1 and GLUT4 mRNA. Several studies have established the blood glucose lowering effect of different ginger extracts, very few have identified the effect on glucose uptake as a possible mechanism of raw ginger in exerting this effect while the effect of cooked ginger extract, the form in which the spice is mostly consumed, on glucose uptake is yet to be explored. This study was therefore designed to determine the effect of raw and cooked ginger extracts on glucose uptake by the muscle and adipose tissue of normal and diabetic rats.

2. Materials and Method

The method of Akhani et al, ²¹ which was used by Elshater et al, ²⁰ was used with slight modification.

Fresh ginger rhizomes (Roscoe variety) were purchased from Bodija market in Ibadan, Nigeria. This was identified and authenticated in the Herbarium Unit of the Department of Botany, University of Ibadan. The rhizomes were washed, peeled, washed and wet-milled (without the addition of water) with a plate attrition mill (Amuda Plate mill, India). This was then sieved with a cheese or muslin cloth and the extract was stored in tightly closed plastic jars at 2°C (at the closest part to the freezer in a refrigerator) until use.

Raw extract was boiled at the medium heat of a 2-burner Thermo cool gas cooker (India) for 1 hour. This was then cooled and stored in plastic jars at 2°C until

The method of Martinello et al ²⁸ was used with slight modification. The composition was as follows: 45% normal rat pellets (Lanko feeds, Nigeria), 30% beef tallow, 20% full cream milk powder (Real Milk, Chellarams) and 5% table sugar. This was formulated weekly to prevent deterioration due to rancidity.

Four weeks old male albino rats (140) of weight range 50-55g were purchased from the Experimental Animal Unit of the Department of Veterinary Physiology, University of Ibadan, Nigeria. These were raised to desired weight range before experimentation commenced. Animals were fed normal rat pellets and tap water ad libitum and were treated according to the research protocol as approved by the U.I/ U.C.H. Ethics Review Committee (Ethical Approval Number-NHREC, 05/01/2008a).

Experimental DM of the two major types (Type 1 and Type 2) was induced in the animals.

Seventy rats of weight range 155-195g were placed in this group. Forty of the rats were rendered diabetic with intraperitoneal injection of streptozocin (Sigma Aldrich, Germany) at the dose of 60mg/kg body weight ¹⁸ in freshly prepared citrate buffer (pH4.5). Fasting blood glucose (FBG) was monitored for 3 days with ACCU-CHEK Active Glucometer (Roche, Germany) until stable hyperglycemia- FBG ≥ 170mg/dl was attained (29). The 70 rats in this group were divided into 7 groups and were designated thus:

NDC- Non-diabetic control group;

NDR- Non-diabetic rats given raw ginger juice (4ml/kg body weight);

NDCo- Non-diabetic rats given cooked ginger;

DC- Diabetic control group;

DR- Diabetic rats given raw ginger juice

DCo- Diabetic rats given cooked ginger juice;

DD- Diabetic rats given glibenclamide (anti-diabetic drug at 5mg/kg body weight).

Seventy rats of weight range 120-160g were used. Hyperglycemia was induced in forty of the rats by feeding them with the High-Fat Diet (HFD) for 12 weeks while the remaining30 rats were fed normal rat pellets (Lanko feeds, Nigeria). After 12 weeks HFD consumption animals with FBG ≥170mg/dl were used for further experimentation. The rats in this group were divided into seven groups and designated thus:

ND₂C- Non-diabetic control group;

ND₂R- Non-diabetic rats given raw ginger extract (2ml/kg body weight);

ND₂Co- Non-diabetic rats given cooked ginger extract;

D₂C- Diabetic control group;

D₂R- Diabetic rats given raw ginger juice (2ml/kg body weight);

D₂Co-Diabetic rats given cooked ginger extract;

D₂D- Diabetic rats given Metformin (200mg/kg body weight).

Raw and cooked ginger extracts (4ml/kg body weight) and the anti-diabetic drugs (glibenclamide for Group 1- 5mg/kg body weight and Metformin for Group 2- 200mg/kg body weight) were administered once daily for 4 weeks with gastric canula according to the designation of the groups above. The extracts’ dosage was reduced to 2ml//kg body weight in the HFD-induced diabetic groups because the animals were showing signs of toxicity with bloodied eye lids after 2 days of administration of 4ml/kg body weight dose)

The method of Gupta et al., ³⁰ was used. Skeletal muscle (Biceps femoris) was isolated from overnight-fasted sacrificed rats. This was identified by a physiologist in the Physiology Department of the University of Ibadan, Nigeria and 0.250g was placed immediately in 5ml of Krebs Ringer Bicarbonate buffer (KRB) containing 11.1mM glucose (pH 7.2). This was done in triplicates for each group in three sets, that is, muscle alone, muscle with insulin (10µl) and muscle with ginger extracts (10µl) or drug as designated in each group. These were then incubated for 2.5hours at 37°C in a CO₂ incubator under 95% air and 5% CO₂. Aliquots of 10µl were removed at 0, 30, 60, 90, 120 and 150 minutes and the glucose content determined using glucose oxidase method with Randox Kit reagents, U.K.

Randox kit reagent, United Kingdom (GL366) was used for this assay. Reagent 1a was mixed with Reagent 1b to form Reagent 1. A small quantity of the aliquot (10µL) was measured into a test tube and 1000µL of Reagent 1 was added after which the test tube was shaken for proper mixing. This procedure was repeated using the standard in place of the sample while for blank only 1000µL of the Reagent 1 was pipetted into a test tube. These were incubated for 25minutes at room temperature (25°C) after which the absorbance of the standard (Astandard) and that of the sample (Asample) against the blank was read within 60 minutes at 546nm. Glucose concentration was calculated thus:

This was performed for this group but not for the STZ-induced diabetic groups because visceral fat was not found in the non-diabetic and STZ-induced diabetic groups. The procedures for the glucose uptake by muscle were repeated here using the adipose tissue in place of skeletal muscle.

Descriptive statistics (mean, standard deviation) and inferential statistics (Analysis of Variance- Least Significant Difference) were used to analyze the data using Statistical Package for Social Science (SPSS) version 17.

3. Result

The result of the effect of raw and cooked ginger extracts on glucose uptake by the muscle of normal and STZ-induced diabetic rats using muscle alone muscle with insulin and muscle with the extract was expressed in Table 1 to Table 3 and summarized in Table 4.

Within the 150 minutes of in vitro experiment in the absence of insulin and extract (Table 1) the percentage glucose taken up by NDC, NDR, DCo, DC, DR, DCo and DD were 41.89, 53.80, 64.29, 41.35, 66.90, 65.35 and 46.68% respectively. The muscle still took up glucose even in the absence of insulin and extract with the peak value observed in DR and the least value in DC. In the set in which insulin was added the percentage of glucose taken within the 150 minutes experimentation by NDC, NDR, NDCo, DC, DR, DCo and DD were 65.50 53.50, 64.82, 42.70, 56.39, 36.74 and 39.54% respectively (Table 2). Insulin was able to enhance glucose uptake only in NDC while in DR, DCo and DD, the percentage of glucose taken up actually reduced. However, in the set in which extracts were added glucose uptake was enhanced by the extracts more than insulin in NDR, DR, DCo and DD (Table 3). The ability of the extracts to enhance glucose uptake by the muscle was clearly evidenced in Table 4 which expressed that the glucose uptake by the muscle in the absence of insulin was higher.

Table 5 to Table 7 show the result of the glucose uptake by the muscle (muscle alone, muscle with insulin and muscle with extract) of normal and HFD –induced diabetic rats and this analysis of which was summarized in Table 8.

The percentage of glucose uptake by the muscle alone (in the absence of insulin and extract) by ND₂C, ND₂R, ND₂Co, D₂C, D₂R, D₂Co and D₂D were 29.03, 31.60, 32.26, 25.11, 26.09, 30.04 and 28.60% respectively (Table 5). In the set in which insulin was added, percentage glucose uptake was 35.20, 33.91, 26.78, 27.96, 34.09, 29.36 and 34.41% in ND₂C, ND₂R, ND₂Co, D₂C, D₂R, D₂Co and D₂D respectively within the 150 minutes in vitro experimentation (Table 6). Insulin enhanced glucose uptake only in ND₂C, D₂R and D₂D compared to values in Table 5 (muscle alone) while this parameter notably reduced in ND₂Co in the presence of insulin. The percentage glucose uptake in the presence of extract (Table 7) was similar to that of muscle alone except in D₂R, D₂Co and D₂D in which a slightly higher result was observed while compared with data obtained when insulin was added glucose uptake was enhanced only in the muscle of rats that were given cooked ginger juice both in non-diabetic and diabetic states (Table 7). However, insulin enhanced glucose uptake in ND₂C, ND₂R, D₂R and D₂D than the extracts and in muscle alone (Table 6). Table 8 is a reflection of the observations in Table 5 to Table 7 in a summary.

The effect of raw and cooked ginger extracts on glucose uptake by the adipose (adipose alone, adipose with insulin, adipose with extract) of normal and HFD-induced diabetic rats was expressed in Table 9 to Table 11 the analysis of which was computed in Table 12.

The adipose of the diabetic control group showed the least percentage of glucose in adipose alone (Table 9), adipose and insulin (Table 10) and adipose and extract (Table 11) while the glucose uptake by adipose alone (Table 9) as well as muscle + extract (Table 11) was comparable to that of the sets in which insulin was added and this was even higher in D2Co, adipose+ extract (Table 11), hence, the extracts enhanced glucose uptake in the absence of insulin. All these are clearly expressed in Table 12 in summary.

4. Discussion

The 4 weeks extracts administration has improved the morphology of the muscle to take up glucose even in the absence of insulin and extracts (Table 4- Muscle alone) as this was reflected in the significant increase in glucose uptake by the extracts’ treated groups both in muscle of normal and diabetic groups. The significant reduction in glucose uptake by the control groups also affirms the fact that ginger extracts and drug administration for 4 weeks enhanced glucose uptake by the muscle and altered the morphology of the muscle to exert this effect since the glucose uptake significantly increased in the absence of insulin and extracts (Table 4-muscle alone).

Insulin enhanced glucose uptake by the muscle of only the non diabetic control (Table 4). The significant reduction in glucose uptake by the muscles of the diabetic-treated groups in the presence of insulin could be due to undesirable interference between the action of insulin and the altered morphology of the muscles of the treated animals. It can therefore be inferred from this that ginger consumption together with the use of insulin may not produce a desirable effect on glucose uptake in STZ-induced diabetic rats or Type 1 diabetic patients.

Raw and cooked ginger extracts increased glucose uptake by 38.95% and 35.75% respectively by the muscle of normal rats while in the muscle of diabetic rats the increase observed was 50.85% and 52.12% respectively and the drug treated animals muscle this was 38.55% (Table 4- muscle + extract) .This shows that ginger extracts were even more effective in enhancing glucose uptake than the drug by the muscle of the treated diabetic animals. This insulin-like activity of ginger affirms the scientific report that ginger exerts insulin-like activity in vitro ³¹. The ability of [6]-gingerol to regulate the gene expression of enzymes related to glucose metabolism towards decreasing gluconeogenesis and glycogenolysis as reported by Son et al.., 2014 which is a similar function of insulin as earlier explained may further ascertain the mimicry of insulin function by ginger. The enhancement of glucose uptake by myotubes of muscles by ethyl acetate ginger extract and gingerol was also observed by Rani et al., ²⁶ and Son et al., ³ in vitro as well as in vivo in obese diabetic mice (3). This marked increase in glucose uptake may be the induction of 5’adenosine monophosphate-activated protein kinase (AMPK) phosphorylation in L6 myotubes and the promotion of glucose transporter 4 (GLUT 4) translocation to cell membrane by [6]-gingerol and ethyl acetate ginger extract ^{3, 26}.

Glucose uptake by the muscle in these groups is lower compared to that of normal and STZ-induced diabetic rats in Table 4 even among the non-diabetic groups. This may be as a result of difference in the age of the animals in the two groups (the STZ-induced diabetic group were 4 months old while the rats in the HFD-induced group were 7 months old) coupled with the HFD diet fed to the HFD-induced diabetic groups. Four weeks administration of raw and cooked ginger extracts increased glucose uptake by the muscle of non-diabetic rats significantly in the absence of insulin and extracts while only the cooked extract and Metformin exerted this effect (Table 8, muscle alone) in the diabetic groups. The residual effect of the extracts and drug treatment could also be seen here.

Insulin enhanced glucose uptake in the muscle of non-diabetic control than that of the non-diabetic rats given raw and cooked ginger extracts. Insulin also significantly increased glucose uptake by the muscles of HFD-induced diabetic rats that were treated with raw, cooked ginger extracts and Metformin by 19.52%, 5.30% and 24.83% respectively compared to the diabetic control.

Introduction of the ginger extracts to the medium in the absence of insulin (Table 8- muscle + extract) increased glucose uptake significantly in the muscle of non-diabetic treated groups though the increase was comparable to that in muscle alone in these two groups.

In the diabetic groups (Table 8-muscle alone) glucose uptake increased by 15.92 % and 9.56% by the muscles of the animals that were treated with cooked extract and Metformin respectively while raw extract did not increase this parameter significantly. Insulin increased glucose uptake significantly by the muscles of diabetic treated rats (Table 8-muscle+insulin) while the extracts and drug increased this parameter significantly (Table 8-muscle+extract) in all the groups compared to the diabetic control. The enhancement of glucose uptake by ginger extracts may be as a result of the ability of [6]-gingerol to increase AMPK α-subunits in L6 skeletal muscle cells which enhanced glucose uptake and prevented high-fat high-calorie diet-induced insulin resistance in rats ³² as well as increasing surface distribution of GLUT 4 proteins on the L6 myotubes plasma membrane in rat skeletal muscle cells ³³.

In the non-diabetic groups, glucose uptake by the adipose tissue significantly increased even in the absence of insulin and extracts showing the residual effect of the extracts on the adipose tissues in enhancing this parameter while in the diabetic rats the increase of glucose uptake by the adipose tissue was 408.81%, 43.51% and 421.85% in diabetic rats given raw, cooked ginger extracts and metformin respectively (Table 12-Adipose alone). This denotes a probable modification of the adipose morphology during the 4 weeks’ extracts and drug administration in favor of glucose uptake.

Introduction of insulin into the medium showed similar effect but glucose uptake was enhanced least by the adipose of diabetic rats given cooked extract (Table 12- adipose + insulin). This shows that the 4 weeks cooked ginger extract administration did not alter the morphology of the adipose enough to enhance glucose uptake effectively as the raw extract and Metformin. This may be due to undesirable nutrient-drug interaction.

However both extracts effect a significant increase in glucose uptake in non-diabetic and diabetic adipose tissues (Table 12-adipose + extracts). In the non-diabetic adipose, the increase was 25.14 and 11.28% in non-diabetic rats given raw and cooked ginger extracts respectively while in the diabetic adipose this was 277.76%, 303.19% and 314.29% in diabetic rats given raw, cooked ginger extracts and metformin respectively. The marked enhancement of glucose uptake by cooked extract here shows that the chronic administration of the extract may not be effective in enhancing this parameter in adipose tissue while the acute administration could be effective. However, the enhancement of differentiation of 3L3-L1 adipocytes by [6]-gingerol ³⁴ coupled with increased peroxisome proliferator-activated receptor gamma (PPARɣ) gene expression and facilitated GLUT4 protein translocation ³⁵ may be responsible for the enhancement of glucose uptake by adipocytes ³⁶.

The enhancement of glucose uptake by the muscle and adipose of the treated rats in this study was reflected in the blood glucose of the animals as reported in the earlier publication of the parts of this study as expressed in Table 13 and Table 14.

At the end of the fourth week of the extracts’ administration blood glucose in non-diabetic rats given raw and cooked ginger extracts reduced from 110.90 and 109.40mg/dl to 81.60 and 83.60mg/dl respectively (Table 13). The blood glucose of the animals at the end of the second week of the extracts’ administration was not significantly different from these. This shows that the medium and long term consumption of the spice in both raw and cooked forms is safe and may not lead to clinically threatening hypoglycemia since the values are still within the normal range in fasted state. In the diabetic groups raw and cooked ginger extracts were as effective as the anti-diabetic drug (glybenclamide) in lowering blood glucose to normal level (Table 13). This blood glucose lowering effect of the ginger extracts is evidently the result of the enhanced glucose uptake as reported above (Table 13).

The blood glucose lowering effect of raw and cooked ginger extracts in the non-diabetic rats was similar to that observed in Table 13 (Table 14). Raw ginger extract on the other hand was more effective in lowering the blood glucose to the normal level than the cooked form in the diabetic groups. The cooked form also had a blood glucose lowering effect. It is therefore clearly evidenced from Tables 13 and 14 that the enhancement of glucose uptake by the ginger extracts and drugs in the absence of insulin which was observed in this study favorably reduced the blood glucose which is the expected outcome showing that raw and ginger extracts may be effective in the dietary management of diabetes mellitus.

5. Conclusion and Recommendation

Raw and cooked ginger extracts increased glucose uptake by the muscle and adipose tissues of normal and diabetic rats even in the absence of insulin, hence, ginger may be insulin-like in activity and could be of significant importance in the diet therapy for the prevention and management of diabetes mellitus. Human trial is hereby recommended.

References